ATE223211T1 - Verwendung von kalzium dobesilat zur herstellung eines arzneimittels zur behandlung von embryonaler zurückgebliebenheit - Google Patents
Verwendung von kalzium dobesilat zur herstellung eines arzneimittels zur behandlung von embryonaler zurückgebliebenheitInfo
- Publication number
- ATE223211T1 ATE223211T1 AT97952124T AT97952124T ATE223211T1 AT E223211 T1 ATE223211 T1 AT E223211T1 AT 97952124 T AT97952124 T AT 97952124T AT 97952124 T AT97952124 T AT 97952124T AT E223211 T1 ATE223211 T1 AT E223211T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- pct
- embryonal
- retention
- production
- Prior art date
Links
- QGNBTYAQAPLTMX-UHFFFAOYSA-L calcium dobesilate Chemical compound [Ca+2].OC1=CC=C(O)C(S([O-])(=O)=O)=C1.OC1=CC=C(O)C(S([O-])(=O)=O)=C1 QGNBTYAQAPLTMX-UHFFFAOYSA-L 0.000 title 1
- 229960005438 calcium dobesilate Drugs 0.000 title 1
- 230000014759 maintenance of location Effects 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 150000001455 metallic ions Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU9603631A HU225149B1 (en) | 1996-12-30 | 1996-12-30 | Use of dobesilate salts for the manufacture of medicaments for the treatment or prevention of embryonic retardation or discordance |
| PCT/HU1997/000090 WO1998029103A2 (en) | 1996-12-30 | 1997-12-30 | Use of calcium dobesilate for the manufacture of a medicament for the treatment of embryonic retardation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE223211T1 true ATE223211T1 (de) | 2002-09-15 |
Family
ID=89994597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97952124T ATE223211T1 (de) | 1996-12-30 | 1997-12-30 | Verwendung von kalzium dobesilat zur herstellung eines arzneimittels zur behandlung von embryonaler zurückgebliebenheit |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5994411A (de) |
| EP (1) | EP0930879B1 (de) |
| JP (1) | JP2000505819A (de) |
| CN (1) | CN1116872C (de) |
| AT (1) | ATE223211T1 (de) |
| DE (1) | DE69715227D1 (de) |
| ES (1) | ES2181051T3 (de) |
| HU (1) | HU225149B1 (de) |
| PT (1) | PT930879E (de) |
| WO (1) | WO1998029103A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2180446B1 (es) * | 2001-07-02 | 2004-01-16 | Esteve Labor Dr | Empleo de derivados de acidos 2,5-dihidroxibencenosulfonicos en la elaboracion de un medicamento para potenciar el efecto de otros farmacos en el tratamiento de la disfuncion erectil. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR6163M (de) * | 1966-01-20 | 1968-07-08 |
-
1996
- 1996-12-30 HU HU9603631A patent/HU225149B1/hu unknown
-
1997
- 1997-12-30 CN CN97192641A patent/CN1116872C/zh not_active Expired - Fee Related
- 1997-12-30 ES ES97952124T patent/ES2181051T3/es not_active Expired - Lifetime
- 1997-12-30 US US09/117,830 patent/US5994411A/en not_active Expired - Fee Related
- 1997-12-30 EP EP97952124A patent/EP0930879B1/de not_active Expired - Lifetime
- 1997-12-30 WO PCT/HU1997/000090 patent/WO1998029103A2/en active IP Right Grant
- 1997-12-30 DE DE69715227T patent/DE69715227D1/de not_active Expired - Lifetime
- 1997-12-30 PT PT97952124T patent/PT930879E/pt unknown
- 1997-12-30 JP JP10529762A patent/JP2000505819A/ja active Pending
- 1997-12-30 AT AT97952124T patent/ATE223211T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1232390A (zh) | 1999-10-20 |
| EP0930879B1 (de) | 2002-09-04 |
| PT930879E (pt) | 2003-01-31 |
| JP2000505819A (ja) | 2000-05-16 |
| HU9603631D0 (en) | 1997-02-28 |
| DE69715227D1 (de) | 2002-10-10 |
| US5994411A (en) | 1999-11-30 |
| HUP9603631A3 (en) | 1999-06-28 |
| EP0930879A2 (de) | 1999-07-28 |
| WO1998029103A2 (en) | 1998-07-09 |
| CN1116872C (zh) | 2003-08-06 |
| ES2181051T3 (es) | 2003-02-16 |
| HU225149B1 (en) | 2006-07-28 |
| WO1998029103A3 (en) | 1998-08-27 |
| HUP9603631A2 (hu) | 1998-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE224374T1 (de) | 1,2-substituierte imidazolylverbindungen zur behandlung von entzündungen | |
| ATE204164T1 (de) | Pflaster zur behandlung von nagelmykosen | |
| ATE172963T1 (de) | Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems | |
| DE69508192T2 (de) | Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen | |
| ATE145136T1 (de) | Verwendung von ketoconazol und ein retinoid zur behandlung der akne vulgaris | |
| ATE303362T1 (de) | Chalcon-derivate mit antiproliferativer aktivität | |
| ATE180669T1 (de) | Verwendung von pregnanderivaten zur behandlung von tumoren | |
| DE69623595D1 (de) | Verfahren zur behandlung hyperproliferativer epithel-läsionen durch topische verabreichung von hydroxylierten aromatischen protein-crosslinking verbindungen | |
| ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| ATE192923T1 (de) | Verwendung von boswelliasäure zur behandlung von hirntumoren | |
| FI973469A0 (fi) | Menetelmä tekijän IX valmistamiseksi biologisista lähteistä | |
| ATE294584T1 (de) | Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz | |
| ATE223211T1 (de) | Verwendung von kalzium dobesilat zur herstellung eines arzneimittels zur behandlung von embryonaler zurückgebliebenheit | |
| ATE252383T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
| HUP0103712A2 (hu) | Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk | |
| AR059965A2 (es) | Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante | |
| ATE234613T1 (de) | Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen | |
| DE69905489D1 (de) | Protein c zur behandlung von sichelzellanämie und thalassämie | |
| DE69620786T2 (de) | Verwendung von cholinesterase-inhibitoren für die herstellung eines medikaments zur behandlung von xerostomie | |
| ATE189385T1 (de) | Verwendung von benzonaphtalene-derivaten zur herstellung eines arzneimittels zur behandlung von krankheiten des nervensystems | |
| ATE320263T1 (de) | Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie | |
| BR0010338A (pt) | Composto enanciomericamente enriquecido, composição farmacêutica, método para tratar uma doença ou condição mediada por cck-a, uso de um composto, e, processo para a preparação de um composto | |
| DE60216090D1 (de) | Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia | |
| MY121344A (en) | Formulated product | |
| DE69909970D1 (de) | Verwendung von 2-amino-6-trifluoromethoxybenzothiazol zur herstellung eines arzneimittels zur vorbeugung oder behandlung von zerebellumkrankheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |